awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26824542-9B328307-A4FC-494F-880A-FDD213362C93
Q26824542-9B328307-A4FC-494F-880A-FDD213362C93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824542-9B328307-A4FC-494F-880A-FDD213362C93
How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer
P2860
Q26824542-9B328307-A4FC-494F-880A-FDD213362C93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824542-9B328307-A4FC-494F-880A-FDD213362C93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1eea7b30ba4fdc65f71ba7cfc1fce4b96cc71df1
P2860
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider